Ultra-High-Dose Methylcobalamin: Safety in ALS Patients

from TheBrief.Health · host TheBrief.Health

Ultra-high dose methylcobalamin is being studied as a potential ALS therapy, offering hope for slowing disease progression and expanding treatment options for patients and families.

Episode metadata supplied by the publisher feed · Published Feb 11, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Ultra-High-Dose Methylcobalamin: Safety in ALS Patients

0:00 1:09

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on February 11, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!